| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.07 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.07 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.091 | 0.07 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |